4basebio PLC (88Q.DE) XETRA

10.20

+0(+0.00%)

Updated at August 18 05:35PM

Currency In EUR

4basebio PLC

Address

25 Norman Way

Cambridge,

United Kingdom of Great Britain and Northern Ireland

Phone

N/A

Sector

Healthcare

Industry

Biotechnology

Employees

101

First IPO Date

November 23, 2021

Key Executives

NameTitlePayYear Born
Dr. Heikki Lanckriet Ph.D.Chief Executive Officer, Chief Scientific Officer & Executive Director524,7551977
Mr. David RothChief Financial Officer, Company Secretary & Executive Director378,1041967
Ms. Amy WalkerChief Operating Officer & Director0N/A
Mr. Gabe LongoriaChief Commercial Officer0N/A

Description

4basebio Plc is a biotechnology company, which engages in the business of developing advanced therapy medicinal products through synthetic DNA products and non-viral, cell targeting nucleic acid delivery platforms. The firm is involved in manufacturing and supplying high quality synthetic DNA products for research, therapeutic, and pharmacological use; and developing target specific non-viral vectors for the efficient delivery of payloads in patients. The company was founded on December 22, 2020 and is headquartered in Cambridge, the United Kingdom.